Bio-K+ CL1285 Probiotic Fights Listeria Monocytogenes Bacteria

Author: Bio-K + International inc.
Published: 2010/08/08 - Updated: 2025/03/29
Publication Details: Peer-Reviewed, Research, Study, Analysis
Topic: Probiotics and Prebiotics - Publications List

Page Content: Synopsis - Introduction - Main - Insights, Updates

Synopsis: This information highlights the benefits of Bio-K+ CL1285®, a probiotic supplement designed to support digestive health and prevent antibiotic-associated diarrhea (AAD). The article explains how the specific strains in Bio-K+, including Lactobacillus acidophilus CL1285 and Lactobacillus casei, have been clinically demonstrated to reduce the risk of AAD and infections like Clostridioides difficile. These probiotics are especially relevant for individuals with weakened immune systems, such as seniors or those with disabilities, as they help restore gut microbiota balance, enhance digestion, and support overall well-being. The supplement’s lactose-free, vegan, and gluten-free formulation ensures accessibility for diverse dietary needs, making it a valuable option for maintaining gastrointestinal health - Disabled World (DW).

Introduction

In the wake of the food crisis currently hitting Canada, biotechnology company Bio-K+ International Inc. believes that it is important to go public with the results of an in vitro study (1) conducted in 2005 by researchers at the INRS- Institut Armand- Frappier. The study, which was published in 2007 in Letters in Applied Microbiology, a peer review journal, demonstrates the effectiveness of Bio-K+ CL1285® in inhibiting the growth of certain pathogenic bacteria, including Listeria monocytogenes.

Main Item

The in vitro experiment conducted by Dr. Mathieu Millette, under the direction of Dr. Monique Lacroix, Professor and Researcher at the INRS-Institut Armand-Frappier, demonstrated that the Bio-K+ CL1285® formula reduced the development of several pathogenic bacteria, including Listeria monocytogenes, in a proportion of 78.4% after a 12-hour incubation. It should be noted that the experiment was conducted with the same formula as the fresh product available in stores and in the same concentration, which is 50 billion friendly bacteria.

According to Mr. Claude Chevalier, the company's President and CEO:

"it goes without saying that this study constitutes a significant indicator of Bio-K+CL1285®'s ability to act on pathogenic bacteria. Although further study is required to understand the full extent of the product's effectiveness in the human body, we think it is crucial that Canadians be aware right now of the results obtained in vitro, because they demonstrate that the product reduces the growth of the pathogenic bacterium, Listeria monocytogenes."

This in vitro research is even more relevant in view of the randomized double-blind study conducted at the Maisonneuve-Rosemont Hospital in 2004 that was recently published in the Canadian Journal of Gastroenterology (2). This study concluded that Bio-K+ CL1285 ® was effective in preventing the antibiotic-associated diarrhea (AAD) in patients in a hospital setting. Other randomized double-blind studies are currently underway to treat patients suffering from traveler's diarrhea, which is often associated to food poisoning, and from AAD in several hospitals as well as from Clostridium difficile.

About Bio-K+ International Inc.

Founded in 1994, Bio-K+ International Inc. is a Quebec-based family biotechnology business that specializes in the production, marketing and distribution of 100% probiotic products. The company, which is headquartered in Laval's Science and High Technology Park, has more than 80 employees in Canada and the United States, and distributes its products in natural food.

(1) Millette, M., F.M. Luquet, M. Lacroix. 2007. In vitro growth control of selected pathogens by Lactobacillus acidophilus and Lactobacillus casei-fermented milk, Letters in Applied Microbiology, Vol. 44. P. 314-319.

(2) Beausoleil, M., N. Fortier, S. Guenette, A. L'Ecuyer, M. Savoie, M. Franco, J. Lachaane, K. Weiss. 2007. Effect of a fermented milk combining Lactobacillus acidophilus CL1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea : A randomized, double-blind, placebo-controlled trial. Canadian Journal of Gastroenterology, Vol. 21. P. 732-736.

Insights, Analysis, and Developments

Editorial Note: The potential of targeted probiotic therapies like Bio-K+ extends beyond digestive health, offering promising avenues for addressing systemic issues such as inflammation and immune function. As research continues to uncover the gut-brain connection, these supplements may play a pivotal role in improving quality of life for vulnerable populations, including seniors and individuals with chronic conditions. However, users should consult healthcare professionals to ensure compatibility with their unique health profiles. - Disabled World (DW).

Attribution/Source(s): This peer reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by Bio-K + International inc. and published on 2010/08/08, this content may have been edited for style, clarity, or brevity. For further details or clarifications, Bio-K + International inc. can be contacted at biokplus.ca NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Explore Similar Topics

• Listeria Bacteria Make Food Poisoning Unpredictable: Listeria bacteria can cause serious and sometimes fatal infections, particularly in the elderly and pregnant women.

• Bio-K+ CL1285 Probiotic Fights Listeria Monocytogenes Bacteria: Information and effectiveness of Probiotic Bio-K+ CL1285® in inhibiting the growth of pathogenic bacteria including Listeria monocytogenes.

• Listeriosis: Causes, Symptoms, Treatment and Prevention: Learn about listeriosis risks, symptoms, prevention tips, and treatments to protect vulnerable groups like seniors, pregnant women, and those with weakened immunity.

• : A scientific group confirms that probiotics are generally safe and provide comprehensive guidance on potential probiotic risks.

• : New specialty beer incorporates probiotic Lactobacillus paracasei L26 which has the ability to neutralise toxins and viruses, as well as regulate the human immune system.

Citing and References

Founded in 2004, Disabled World (DW) is a leading resource on disabilities, assistive technologies, and accessibility, supporting the disability community. Learn more on our About Us page.

Cite This Page: Bio-K + International inc.. (2010, August 8 - Last revised: 2025, March 29). Bio-K+ CL1285 Probiotic Fights Listeria Monocytogenes Bacteria. Disabled World (DW). Retrieved April 25, 2025 from www.disabled-world.com/medical/alternative/probiotics/bio-k-cl1285-probiotic.php

Permalink: <a href="https://www.disabled-world.com/medical/alternative/probiotics/bio-k-cl1285-probiotic.php">Bio-K+ CL1285 Probiotic Fights Listeria Monocytogenes Bacteria</a>: Bio-K+ CL1285® supports gut health, reduces antibiotic-associated diarrhea, and promotes overall well-being with its clinically proven probiotic strains.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.